Effects of bone-targeted agents on cancer progression and mortality. [electronic resource]
Producer: 20120925Description: 1059-67 p. digitalISSN:- 1460-2105
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- pharmacology
- Bone Density Conservation Agents -- pharmacology
- Bone Neoplasms -- drug therapy
- Breast Neoplasms -- drug therapy
- Denosumab
- Diphosphonates -- pharmacology
- Disease Progression
- Disease-Free Survival
- Female
- Goserelin -- therapeutic use
- Humans
- Imidazoles -- therapeutic use
- Male
- Menopause
- Neoplasms -- drug therapy
- Prostatic Neoplasms -- drug therapy
- Survival Rate
- Treatment Outcome
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.